US pharmaceutical company Eli Lilly, Swiss Novartis and Danish Novo Nordisk are potential bidders to acquire Danish biotechnology company Ascendis Pharma, according to an informed source.
US pharmaceutical company Eli Lilly, Swiss Novartis and Danish Novo Nordisk are potential bidders to acquire Danish biotechnology company Ascendis Pharma, according to an informed source.